IR News

Nxera Pharma Webinar for Financial Results 3Q2026/ R&D Presentation

Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for 3Q 2026 on Friday, 30 October 2026.

The Company will host a live webinar presentation with Chris Cargill (President, CEO), Hironoshin Nomura (CFO), Toshi Maeda (COO) and Patrik Foerch (CSO and President of Nxera Pharma UK), at 5:00 pm JST (8:00 am GMT) on Friday, 30 October 2026. 

The webinar is open to all existing and potential investors as well as sell-/buy-side analysts and will consist of a presentation followed by a Q&A session. Please click here to pre-register, which will provide a link to access the webinar.

Presentation slides will be made available by 4:30 pm JST (7:30 am GMT) on 30 October 2026 through the investor section of the Company’s Home Page here.